We have data on 43 companies that use Merge eClinical OS. The companies using Merge eClinical OS are most often found in United States and in the Hospital & Health Care industry. Merge eClinical OS is most often used by companies with >10000 employees and >1000M dollars in revenue. Our data for Merge eClinical OS usage goes back as far as 3 years.
|DFINE Inc.||dfineinc.com||United States||10M-50M||50-200|
|Northwestern University||northwestern.edu||United States||>1000M||>10000|
|Quintiles Transnational Holdings||quintiles.com||United States||>1000M||>10000|
|Saint Louis University||slu.edu||United States||200M-1000M||>10000|
|Endologix Inc||endologix.com||United States||100M-200M||500-1000|
We use the best scanning techniques combined with advanced data science to monitor the market share of over 5,000 technology products, including Healthcare. In the Healthcare category, Merge eClinical OS has a market share of about 0.1%. Other major and competing products in this category include:
Merge eClinical OS is an unified platform designed to help clients manage and run studies faster and more cost effectively. Users benefit from the convenience of one operating platform with clinical trial capabilities that can be mixed and matched to build a solid foundation for each trial environment. The system includes everything needed to design, deploy, and manage clinical trials - from Electronic Data Capture to Randomization to Endpoint and Adjudication Management, and much more.
Looking at Merge eClinical OS customers by industry, we find that Hospital & Health Care (20%), Medical Devices (15%), Pharmaceuticals (13%), Higher Education (10%) and Computer Software (6%) are the largest segments.
87% of Merge eClinical OS customers are in United States and 5% are in United Kingdom.